Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Sep 1;158(3):901–919. doi: 10.1084/jem.158.3.901

Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice

PMCID: PMC2187088  PMID: 6224885

Abstract

MRL/lpr/lpr (MRL/l) mice develop a lupus-like syndrome and a disease histologically and serologically similar to human rheumatoid arthritis. Their sera contain polyclonal IgM rheumatoid factors (RF) reactive with all murine IgG subclasses (frequently strongest with IgG2a) and several heterologous IgG. To examine the repertoire and epitopic specificities of these RF, we fused splenocytes from 3.5-mo-old seropositive MRL/l mice with appropriate myeloma partners and derived 1,723 hybridomas of which 23 secreted IgMRF. These monoclonal IgMRF bound to murine IgG only, not to other murine isotypes. Eight murine IgG subclass-specific clonotypes were identified. Most clones reacted with either multiple IgG subclasses or with IgG2a alone. A few clones reacted solely with IgG2b but none reacted exclusively with IgG1 or IgG3. Monoclonal IgMRF with exclusively anti-IgG2a activity exhibited allotypic specificity, reacting, with few exceptions, with a, c, and e, but not b, d, or j IgG2a allotypes. Four clonotypes could be distinguished by cross- reactivity with IgG from species other than mice. Monoclonals possessing activity against several murine subclasses cross-reacted extensively with heterologous IgG, including all human IgG subclasses without allotypic restrictions. Monoclonal IgMRF specific for murine IgG2a or 2b did not cross-react with heterologous IgG. Based on the absence of cross-reactions by IgG2a-specific monoclonal autoantibodies, certain peptides of the IgG CH2 and CH3 domains appear to generate the antigenic determinants of the anti-IgG2a RF in MRL/l mice. All of the monoclonal RF bound to Fc and, with one exception, not to Fab fragments of murine IgG. Binding of the monoclonal RF to substrate IgG was not inhibited by Clq, thus excluding the Clq-binding site at the CH2 domain as one of the responsible epitopes in the induction of MRL/l RF. mIgMRF could be categorized as strongly, weakly, or noninhibitable by protein A, which interacts with IgG molecules at or near the CH2-CH3 junction. Inhibition appears to be caused by conformational changes and/or steric shielding of certain IgG areas distant from this junction and not by identical binding sites between protein A and RF. Certain of the mIgMRF that were weakly or not at all inhibitable by protein A were found to cross-react equally well with human Fc (CH2-CH3 domains) and pFc' (CH3 domain) fragments, indicating that the binding site for these monoclonals is at the CH3 domain. Monoclonal RF were devoid of anti- double-strand DNA, anticollagen, or antipeptidoglycan pentapeptide cross-reactivity, but one of the monoclonals cross-reacted with histones, four with single-strand DNA, and one with both histones and single-strand DNA.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Arbetter A., Ibanez de Kasep G., Powell R., Tan E. M., Joslin F. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med. 1980 Jun 1;151(6):1514–1527. doi: 10.1084/jem.151.6.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andriopoulos N. A., Mestecky J., Miller E. J., Bradley E. L. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 1976 May-Jun;19(3):613–617. doi: 10.1002/art.1780190314. [DOI] [PubMed] [Google Scholar]
  4. Andrzejewski C., Jr, Stollar B. D., Lalor T. M., Schwartz R. S. Hybridoma autoantibodies to DNA. J Immunol. 1980 Mar;124(3):1499–1502. [PubMed] [Google Scholar]
  5. BUTLER V. P., Jr, VAUGHAN J. H. THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. Immunology. 1965 Feb;8:144–159. [PMC free article] [PubMed] [Google Scholar]
  6. Bokisch V. A., Chiao J. W., Bernstein D., Krause R. M. Homogenous rabbit 7S anti-IgG with antibody specificity for peptidoglycan. J Exp Med. 1973 Nov 1;138(5):1184–1193. doi: 10.1084/jem.138.5.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bonagura V. R., Kunkel H. G., Pernis B. Cellular localization of rheumatoid factor idiotypes. J Clin Invest. 1982 Jun;69(6):1356–1365. doi: 10.1172/JCI110575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burton D. R., Boyd J., Brampton A. D., Easterbrook-Smith S. B., Emanuel E. J., Novotny J., Rademacher T. W., van Schravendijk M. R., Sternberg M. J., Dwek R. A. The Clq receptor site on immunoglobulin G. Nature. 1980 Nov 27;288(5789):338–344. doi: 10.1038/288338a0. [DOI] [PubMed] [Google Scholar]
  9. Cann G. M., Zaritsky A., Koshland M. E. Primary structure of the immunoglobulin J chain from the mouse. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6656–6660. doi: 10.1073/pnas.79.21.6656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Capra J. D., Kehoe J. M. Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4032–4036. doi: 10.1073/pnas.71.10.4032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Capra J. D., Kehoe J. M., Winchester R. J., Kunkel H. G. Structure-function relationships among anti-gamma globulin antibodies. Ann N Y Acad Sci. 1971 Dec 31;190:371–381. doi: 10.1111/j.1749-6632.1971.tb13549.x. [DOI] [PubMed] [Google Scholar]
  12. Capra J. D., Winchester R. J., Kunkel H. G. Hypergammaglobulinemic purpura. Studies on the unusual anti- -globulins characteristic of the sera of these patients. Medicine (Baltimore) 1971 Mar;50(2):125–138. [PubMed] [Google Scholar]
  13. Carson D. A., Bayer A. S., Eisenberg R. A., Lawrance S., Theofilopoulos A. IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes. Clin Exp Immunol. 1978 Jan;31(1):100–103. [PMC free article] [PubMed] [Google Scholar]
  14. Connell G. E., Painter R. H. Fragmentation of immunoglobulin during storage. Can J Biochem. 1966 Mar;44(3):371–379. doi: 10.1139/o66-044. [DOI] [PubMed] [Google Scholar]
  15. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 1981 Apr 28;20(9):2361–2370. [PubMed] [Google Scholar]
  16. Eilat D., Ben Sasson S. A., Laskov R. A ribonucleic acid-specific antibody produced during autoimmune disease: evidence for nucleotide sequence specificity. Eur J Immunol. 1980 Nov;10(11):841–845. doi: 10.1002/eji.1830101108. [DOI] [PubMed] [Google Scholar]
  17. Eisenberg R. A., Thor L. T., Dixon F. J. Serum-serum interactions in autoimmune mice. Arthritis Rheum. 1979 Oct;22(10):1074–1081. doi: 10.1002/art.1780221005. [DOI] [PubMed] [Google Scholar]
  18. Eisenberg R. A., Winfield J. B., Cohen P. L. Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol. 1982 Nov;129(5):2146–2149. [PubMed] [Google Scholar]
  19. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  20. Fougereau M., Bourgois A., de Preval C., Rocca-Serra J., Schiff C. The complete sequence of the murine monoclonal immunoglobulin MOPC 173 (IgG2a): genetic implications. Ann Immunol (Paris) 1976 Sep-Oct;127(5):607–631. [PubMed] [Google Scholar]
  21. Førre O., Dobloug J. H., Michaelsen T. E., Natvig J. B. Evidence of similar idiotypic determinants on different rheumatoid factor populations. Scand J Immunol. 1979 Mar;9(3):281–289. doi: 10.1111/j.1365-3083.1979.tb02732.x. [DOI] [PubMed] [Google Scholar]
  22. GRUBB R., LAURELL A. B. Hereditary serological human serum groups. Acta Pathol Microbiol Scand. 1956;39(6):390–398. doi: 10.1111/j.1699-0463.1956.tb05067.x. [DOI] [PubMed] [Google Scholar]
  23. Hang L., Theofilopoulos A. N., Dixon F. J. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med. 1982 Jun 1;155(6):1690–1701. doi: 10.1084/jem.155.6.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hannestad K., Rekvig O. P., Husebekk A. Cross-reacting rheumatoid factors and lupus erythematosus (LE)-factors. Springer Semin Immunopathol. 1981;4(2):133–160. doi: 10.1007/BF01857092. [DOI] [PubMed] [Google Scholar]
  25. Izui S., Eisenberg R. A. Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. Clin Immunol Immunopathol. 1980 Mar;15(3):536–551. doi: 10.1016/0090-1229(80)90065-3. [DOI] [PubMed] [Google Scholar]
  26. Johnson P. M., Faulk W. P. Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis. Clin Immunol Immunopathol. 1976 Nov;6(3):414–430. doi: 10.1016/0090-1229(76)90094-5. [DOI] [PubMed] [Google Scholar]
  27. Kearney J. F., Radbruch A., Liesegang B., Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol. 1979 Oct;123(4):1548–1550. [PubMed] [Google Scholar]
  28. Kunkel H. G., Agnello V., Joslin F. G., Winchester R. J., Capra J. D. Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med. 1973 Feb 1;137(2):331–342. doi: 10.1084/jem.137.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kunkel H. G., Winchester R. J., Joslin F. G., Capra J. D. Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities. J Exp Med. 1974 Jan 1;139(1):128–136. doi: 10.1084/jem.139.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Langone J. J. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol. 1982;32:157–252. [PubMed] [Google Scholar]
  31. McConahey P. J., Dixon F. J. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 1980;70(A):210–213. doi: 10.1016/s0076-6879(80)70050-2. [DOI] [PubMed] [Google Scholar]
  32. Metzger H. Structure and function of gamma M macroglobulins. Adv Immunol. 1970;12:57–116. doi: 10.1016/s0065-2776(08)60168-6. [DOI] [PubMed] [Google Scholar]
  33. Morgan E. L., Hugli T. E., Weigle W. O. Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5388–5391. doi: 10.1073/pnas.79.17.5388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Natvig J. B., Gaarder P. I., Turner M. W. IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol. 1972 Oct;12(2):177–184. [PMC free article] [PubMed] [Google Scholar]
  35. Natvig J. B., Kunkel H. G. Human immunoglobulins: classes, subclasses, genetic variants, and idiotypes. Adv Immunol. 1973;16:1–59. doi: 10.1016/s0065-2776(08)60295-3. [DOI] [PubMed] [Google Scholar]
  36. Nemazee D. A., Sato V. L. Enhancing antibody: a novel component of the immune response. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3828–3832. doi: 10.1073/pnas.79.12.3828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pages J. M., Bussard A. E. Establishment and characterization of a permanent murine hybridoma secreting monoclonal autoantibodies. Cell Immunol. 1978 Nov;41(1):188–194. doi: 10.1016/s0008-8749(78)80038-0. [DOI] [PubMed] [Google Scholar]
  38. Porter R. R., Reid K. B. The biochemistry of complement. Nature. 1978 Oct 26;275(5682):699–704. doi: 10.1038/275699a0. [DOI] [PubMed] [Google Scholar]
  39. Rubin R. L., Joslin F. G., Tan E. M. A solid-phase radioimmunoassay for anti-histone antibodies in human sera: comparison with an immunofluorescence assay. Scand J Immunol. 1982 Jan;15(1):63–70. doi: 10.1111/j.1365-3083.1982.tb00622.x. [DOI] [PubMed] [Google Scholar]
  40. Steinitz M., Tamir S. Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line. Eur J Immunol. 1982 Feb;12(2):126–133. doi: 10.1002/eji.1830120206. [DOI] [PubMed] [Google Scholar]
  41. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tenner A. J., Lesavre P. H., Cooper N. R. Purification and radiolabeling of human C1q. J Immunol. 1981 Aug;127(2):648–653. [PubMed] [Google Scholar]
  43. Theofilopoulos A. N., Dixon F. J. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55:179–216. doi: 10.1111/j.1600-065x.1981.tb00343.x. [DOI] [PubMed] [Google Scholar]
  44. Van Snick J. L. A gene linked to the Igh-C locus controls the production of rheumatoid factor in the mouse. J Exp Med. 1981 Mar 1;153(3):738–742. doi: 10.1084/jem.153.3.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Van Snick J. L., Coulie P. Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice. J Exp Med. 1982 Jan 1;155(1):219–230. doi: 10.1084/jem.155.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. WILLIAMS R. C., Jr, KUNKEL H. G. Antibodies to rabbit gamma-globulin after immunizing with various preparations of autologous gamma-globulin. Proc Soc Exp Biol Med. 1963 Mar;112:554–561. doi: 10.3181/00379727-112-28104. [DOI] [PubMed] [Google Scholar]
  47. WILLIAMS R. C., Jr, KUNKEL H. G. SEPARATION OF RHEUMATOID FACTORS OF DIFFERENT SPECIFICITIES USING COLUMNS CONJUGATED WITH GAMMA-GLOBULIN. Arthritis Rheum. 1963 Dec;6:665–675. doi: 10.1002/art.1780060602. [DOI] [PubMed] [Google Scholar]
  48. Yasmeen D., Ellerson J. R., Dorrington K. J., Painter R. H. The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1. J Immunol. 1976 Feb;116(2):518–526. [PubMed] [Google Scholar]
  49. van Snick J. L., Masson P. L. Age-dependent production of IgA and IgM autoantibodies against IgG2a in a colony of 129/Sv mice. J Exp Med. 1979 Jun 1;149(6):1519–1530. doi: 10.1084/jem.149.6.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. van Snick J. L., Masson P. L. Incidence and specificities of IgA and IgM anti-AgG autoantibodies in various mouse strains and colonies. J Exp Med. 1980 Jan 1;151(1):45–55. doi: 10.1084/jem.151.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES